NCT02519348 · Interventional trial
A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma
Overall registry status Active not recruiting
Phase 2
Conditions Hepatocellular Carcinoma
Delaware Valley sites
- Research Site · Philadelphia, PA · Philadelphia County
- Research Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory